Search - tctmd.com

Displaying 221 - 240 of 317

Sort: Relevancy | Date

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

News Daily News

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

January 14, 2019

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

January 10, 2019

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

News Daily News

Operators’ Radiation Exposure in the Cath Lab Directly Tied to Patient BMI

January 04, 2019

NOACs Significantly Curb Risk of VTE in Cancer Patients

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

December 06, 2018

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

November 15, 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

News Conference News AHA 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Yael L. Maxwell

November 10, 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

November 10, 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

News Conference News AHA 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

November 10, 2018

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality

News Daily News

Higher Fitness Again Tied to a Lower Risk of Death, Including CVD Mortality

Michael O'Riordan

October 30, 2018

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

News Daily News

Statin Benefits: Yes for CVD but No for Everything Else, Says New Review

Michael O'Riordan

October 08, 2018

Aspirin Falters Yet Again in Primary Prevention: ASPREE

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

News Daily News

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

September 13, 2018

Physical Activity in Short Supply Worldwide, WHO Researchers Find

News Daily News

Physical Activity in Short Supply Worldwide, WHO Researchers Find

September 12, 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

News Conference News ESC 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Michael O'Riordan

August 28, 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

August 26, 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

August 26, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.